Clinical Trials Browser

Phase 2 × alectinib × 1 year × Clear all

NCT04302025 2026-05-22

NAUTIKA1

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT04589845 2026-05-08

Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study

Phase 2 Active not recruiting

920 enrolled 1 FDA

Other solid neoplasm

Solid Tumors

NCT02314481 2026-05-04

DARWINII

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Genomic Instability

NCT04116541 2026-04-24

MegaMOST

Phase 2 Recruiting

Neoplasm Metastasis

NCT03737994 2026-04-23

Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer

Phase 2 Terminated

10 enrolled 17 charts

Lung Neoplasms

NCT03498521 2025-11-19

CUPISCO

Phase 2 Completed

529 enrolled 16 charts

Neoplasms, Unknown Primary

NCT04341181 2025-07-25

ProTarget

Phase 2 Recruiting

Neoplasms